European equities traded in the US as American depositary receipts were edging higher late Wednesday morning, up 0.2% to 1,940.47 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and semiconductor firm Sequans Communications (SQNS), which rose 3.6% and 3.3% respectively. They were followed by argenx (ARGX) and Novo Nordisk (NVO), which rose 3.2% and 2.8% respectively.
The decliners from continental Europe were led by internet ad firm Criteo (CRTO) and biopharmaceutical company Cellectis (CLLS), which dropped 18% and 1.8% respectively. They were followed by telecommunications company Nokia (NOK) and biopharmaceutical company Grifols (GRFS), which were down 1.5% and 1.3% respectively.
The gainers from the UK were led by pharmaceutical company AstraZeneca (AZN) and communications company WPP (WPP), which increased 4.6% and 3.4% respectively. They were followed by educational publisher Pearson (PSO) and hospitality company Intercontinental Hotels Group (IHG), which were up 2.5% and 2.1% respectively.
The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals (BDRX) and insurance company Prudential (PUK), which fell 8.1% and 4.7% respectively. They were followed by Akari Therapeutics (AKTX) and lender HSBC (HSBC), which lost 3.6% and 3.2% respectively.